Cryoglobulinaemia refers to the serum presence of cryoglobulins, which are defined as
immunoglobulins that precipitate at temperatures< 37° C. Type I cryoglobulinaemia consists …

Cryoglobulins are present in about a quarter of patients with hepatitis C; in some,
cryoglobulinemia can become symptomatic or even life-threatening. This review …

OBJECTIVE: The objective of this review was to define a core set of recommendations for
the treatment of HCV-associated mixed cryoglobulinemia syndrome (MCS) by combining …

In addition to its effects in the liver, chronic hepatitis C virus (HCV) infection can have serious
consequences for other organ systems. Extrahepatic manifestations include mixed …

OBJECTIVE: Mixed cryoglobulinemia syndrome (MCs) is a systemic vasculitis characterized
by multiple organ involvement due to the vascular deposition of immune-complexes, mainly …

Hepatitis C virus (HCV) is both hepatotrophic and lymphotropic virus that causes liver as
well extrahepatic manifestations including cryoglobulinemic vasculitis, the most frequent and …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 11th Annual Workshop on Advances in …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 13th Annual Workshop on Advances in …

Cryoglobulinemic vasculitis (CV) or mixed cryoglobulinemic syndrome (MCS) is a systemic
small-vessel vasculitis characterized by the proliferation of B-cell clones producing …

Objective Management of nonviral cryoglobulinemia vasculitis has yet to be defined.
Rituximab has emerged as a novel and promising therapeutic alternative, but data are …